Details for Patent: 7,977,488
✉ Email this page to a colleague
Which drugs does patent 7,977,488 protect, and when does it expire?
Patent 7,977,488 protects VOQUEZNA TRIPLE PAK, VOQUEZNA DUAL PAK, and VOQUEZNA, and is included in three NDAs.
This patent has fifty-eight patent family members in thirty-three countries.
Summary for Patent: 7,977,488
| Title: | 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors |
| Abstract: | The present invention provides a compound having a superior acid secretion inhibitory effect and showing an antiulcer activity and the like. The present invention provides a compound represented by the formula (I) wherein R.sup.1 is a nitrogen-containing monocyclic heterocyclic group optionally condensed with a benzene ring or a heterocycle, the nitrogen-containing monocyclic heterocyclic group optionally condensed with a benzene ring or a heterocycle optionally has substituent(s), R.sup.2 is an optionally substituted C.sub.6-14 aryl group, an optionally substituted thienyl group or an optionally substituted pyridyl group, R.sup.3 and R.sup.4 are each a hydrogen atom, or one of R.sup.3 and R.sup.4 is a hydrogen atom and the other is an optionally substituted lower alkyl group, an acyl group, a halogen atom, a cyano group or a nitro group, and R.sup.5 is an alkyl group or a salt thereof. ##STR00001## |
| Inventor(s): | Kajino; Masahiro (Osaka, JP), Hasuoka; Atsushi (Osaka, JP), Nishida; Haruyuki (Osaka, JP) |
| Assignee: | Takeda Pharmaceutical Company Limited (Osaka, JP) |
| Application Number: | 11/991,307 |
|
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 7,977,488
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Phathom | VOQUEZNA TRIPLE PAK | amoxicillin; clarithromycin; vonoprazan fumarate | CAPSULE, TABLET, TABLET;ORAL | 215152-001 | May 3, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Phathom | VOQUEZNA DUAL PAK | amoxicillin; vonoprazan fumarate | CAPSULE, TABLET;ORAL | 215153-001 | May 3, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Phathom | VOQUEZNA | vonoprazan fumarate | TABLET;ORAL | 215151-001 | Nov 1, 2023 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Phathom | VOQUEZNA | vonoprazan fumarate | TABLET;ORAL | 215151-002 | Nov 1, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,977,488
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2005-250356 | Aug 30, 2005 |
| Japan | 2006-100626 | Mar 31, 2006 |
| PCT Information | |||
| PCT Filed | August 29, 2006 | PCT Application Number: | PCT/JP2006/317408 |
| PCT Publication Date: | March 08, 2007 | PCT Publication Number: | WO2007/026916 |
International Family Members for US Patent 7,977,488
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 055144 | ⤷ Sign Up | |||
| Argentina | 107852 | ⤷ Sign Up | |||
| Austria | E504567 | ⤷ Sign Up | |||
| Australia | 2006285641 | ⤷ Sign Up | |||
| Brazil | 122017028096 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
